Загрузка...
Nanoparticle Delivery of RIG-I Agonist Enables Effective and Safe Adjuvant Therapy in Pancreatic Cancer
Local immunomodulation can be a promising strategy to augment the efficacy and decrease off-target toxicities associated with cancer treatment. Pancreatic cancer is resistant to immunotherapies due to the immunosuppressive tumor microenvironment. Herein, we investigated a therapeutic approach involv...
Сохранить в:
| Опубликовано в: : | Mol Ther |
|---|---|
| Главные авторы: | , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
American Society of Gene & Cell Therapy
2019
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6401191/ https://ncbi.nlm.nih.gov/pubmed/30545600 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ymthe.2018.11.012 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|